Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Seminars in Clinical Psychopharmacology

Seminars in Clinical Psychopharmacology

9781911623458
302,34 zł
272,10 zł Zniżka 30,24 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 272,10 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
This greatly expanded third edition provides a comprehensive overview of clinical psychopharmacology, incorporating the major advances in the field since the previous editions publication. Renowned experts from psychiatry, pharmacy, and nursing have integrated basic science, psychopharmacology, and clinical practice throughout the book in order to provide a thorough basis for prescribing. It covers all key psychiatric drugs and disorders and includes the latest data on efficacy, safety and tolerability. Adopting a pragmatic approach to drug nomenclature, both Neuroscience-based Nomenclature (NbN) and older generic terminology are included in the text reflecting that clinicians are likely to use both systems. Many chapters refer to current National Institute of Health and Care Excellence (NICE) guidelines, making this a crucial resource. Edited by leading authorities in the field, Professor Peter M. Haddad and Professor David J. Nutt, Seminars in Clinical Psychopharmacology emphasises evidence-based prescribing with the aim of achieving better clinical outcomes for patients.
Szczegóły produktu
Cambridge University Press
88567
9781911623458
9781911623458

Opis

Rok wydania
2020
Numer wydania
3
Oprawa
miękka foliowana
Liczba stron
690
Wymiary (mm)
158.00 x 233.00
Waga (g)
1150
  • List of contributors; Foreword Peter Tyrer; Preface; Editors note on nomenclature; Neuroscience-based nomenclature glossary; List of abbreviations; Part I. Basic Science and General Principles:: 1. A brief history of psychopharmacology Peter M. Haddad, David J. Nutt and Richard Green; 2. Psychiatric drug discovery and development Mohammed Shahid, Joanna C. Neill and John Hutchison; 3. Neurotransmission and mechanisms of drug action Brian E. Leonard; 4. Pharmacodynamics and pharmacokinetics Stuart Gill-Banham and David Taylor; 5. Pharmacogenomics and psychopharmacology Diego L. Lapetina, Esther H. Yang, Beatriz C. Henriques and Katherine J. Aitchison; 6. Good clinical practice in psychopharmacology Peter M. Haddad and Thomas R. E. Barnes; Part II. Psychopharmacology of the Main Psychotropic Drug Groups:: 7. Drugs to treat depression Patrick McLaughlin and Anthony Cleare; 8. Drugs to treat anxiety and insomnia David S. Baldwin and Nathan Huneke; 9. Drugs to treat schizophrenia and psychosis (dopamine antagonists and partial agonists other than clozapine) Robert McCutcheon, Stephen J. Kaar and Oliver D. Howes; 10. Clozapine Richard Drake; 11. Lithium Allan H. Young and Dilveer S. Sually; 12. Anticonvulsants for mental disorders:: valproate, lamotrigine, carbamazepine, and oxcarbazepine Peter S. Talbot; 13. Drugs to treat attention deficit hyperactivity disorder (ADHD) Ulrich Müller-Sedgwick and Jane A. Sedgwick-Müller; 14. Drugs to treat dementia Ross Dunne and Alistair Burns; 15. Drugs to treat substance use disorder (SUD) Julia Sinclair and Lesley Peters; 16. ECT and neuromodulation therapies David Christmas and Keith Matthews; Part III. Specific Therapeutic Areas:: 17. Drug treatment in childhood and adolescence David Coghill and Nicoletta Adamo; 18. Drug treatment in later life Simon J. C. Davies; 19. Prescribing in pregnancy and lactation Angelika Wieck and Ian Jones; 20. The clinical management of acute disturbance including rapid tranquilisation Faisil Sethi, Caroline Parker, Aileen OBrien and Maxine X. Patel; 21. Antipsychotics, weight gain and metabolic risk Stephen J. Cooper and Gavin P. Reynolds; Index.
Komentarze (0)